Thompson's hematologist at Johns Hopkins, Dr. Robert A. Brodsky, published a study revealing that the research now has an overall 94% disease-free survival rate.
"[A cure is now] available to the majority, almost the entirety, of sickle cell patients.”
#GoodNews #BlackSky 🌱
Tatyana Thompson, who was diagnosed with sickle cell disease when she was 2 months old, was successfully cured of the disease after she participated in Johns Hopkins research on sickle cell treatment.
